Skip to main content
. 2022 Nov 30;10(2):nwac275. doi: 10.1093/nsr/nwac275

Figure 2.

Figure 2.

Manipulation of VPLGlu neurons affects pain perception in mice. (a) Schematic of the experimental procedure. (b) Representative images of the injection site of AAV-CaMKII-hM4Di-mCherry (left) and mCherry-labeled neurons (red) co-labeled with glutamate immunofluorescence (green, right) within the VPL. Scale bars, 200 μm (left) or 20 μm (right). (c) Schematic of virus injection and the recording configuration. (d) Whole-cell recordings showing the effect of CNO on AAV-DIO-hM4Di-mCherry expressing VPLGlu neurons. (e and f) Representative traces (e) and summarized data (f) of spontaneous spikes in VPLGlu neurons of sham and SNI 7D mice infected with mCherry or hM4Di-mCherry within the VPL. (g) Effects of chemogenetic inhibition of VPLGlu neurons on the pain threshold in SNI 7D mice. (h) Schematic of optogenetic experiments in C57 mice. (i) Images showing that the injection site within VPL of AAV-CaMKII-ChR2-mCherry (left) and mCherry-labeled neurons (red) co-localized with glutamate (Glu) immunofluorescence (right). Scale bars, 200 μm (left) or 10 μm (right). (j) Schematic of VPL injection of CaMKII-ChR2-mCherry in C57 mice and recording configuration in acute slices. (k) Sample traces of action potentials evoked by light (473 nm, 20 ms, blue line) recorded from VPLGlu neurons in acute brain slices. (l) Effects of optogenetic activation of VPLGlu neurons on the pain threshold in naive mice. All data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. For detailed statistics information, see Table S1.